FindTrial
Sign In

A randomized controlled trial: Effects of Primo Vision (Time-lapse) technology on the IVF outcome of patients undergoing assisted reproductive technology

A randomized controlled trial: Effects of Primo Vision (Time-lapse) technology on the IVF outcome of patients undergoing assisted reproductive technology

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800014292
Enrollment
Unknown
Registered
2018-01-04
Start date
2018-01-05
Completion date
Unknown
Last updated
2018-09-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

assisted reproductive technology

Interventions

Timelapse Group:Timelapse obersavation
tranditional IVF Group:no intervention

Sponsors

Peking University Shenzhen Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 38 Years

Inclusion criteria

Inclusion criteria: 1. COH; 2. The in vitro fertilization mode is IVF or ICSI; 3. Aged 10.

Exclusion criteria

Exclusion criteria: Oocytes maturation rate <50%, fertilization rate <60%, pelvic endometriosis, adenomyosis, uterine fibroids, recurrent abortion or implantation failure.

Design outcomes

Primary

MeasureTime frame
Blastocyst formation rate;—

Secondary

MeasureTime frame
clinical pregnancy rate;—

Countries

China

Contacts

Public ContactZhou Liang

Reproductive Medical Center, Peking University Shenzhen Hospital

zhouliang1002@163.com+86 13500054029

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026